C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2006
11/30/2006	US20060270841 Assays to monitor amyloid precursor protein processing
11/30/2006	US20060270840 Pentopyranosyl nucleic acid conjugates
11/30/2006	US20060270838 covalent heterodimer of two different neurotrophins; which have multiple neurotrophic specificities; use in treatment of nervous system disorders
11/30/2006	US20060270835 Diagnosis and treatment of Alzheimer disease
11/30/2006	US20060270833 Peptide complex
11/30/2006	US20060270624 Gapped 2' modified oligonucleotides
11/30/2006	US20060270623 RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)
11/30/2006	US20060270621 Inhibition of hair growth with RNAi targeting desmoglein 4 and nude mRNAs
11/30/2006	US20060270619 Polynucleotide used in diagnosis of cell proliferative disease, and as target molecules for developing drugs
11/30/2006	US20060270595 Nucleic acids encoding compositions of THAP-family chemokine binding domains
11/30/2006	US20060270593 Novel molecules of the PYRIN/NBS/LRR protein family and uses thereof
11/30/2006	US20060270591 Androgen receptor coregulators
11/30/2006	US20060270010 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
11/30/2006	US20060270007 Method for producing glucoamylases and their uses
11/30/2006	US20060270006 Xylanases having increased stability in harsh industrial environments, such as increased pH and/or temperature
11/30/2006	US20060270005 Genomic library of cyanophage s-2l and functional analysis
11/30/2006	US20060270003 Nucleotide sequences coding imterleukin-17 polypeptide for use in diagnosis, prevention and treatment of bone, autoimmune, skin and inflammatory disorders
11/30/2006	US20060270002 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060270001 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060270000 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060269999 Promoters
11/30/2006	US20060269998 Methods and compositions to modulate adhesion and stress tolerance in bacteria
11/30/2006	US20060269997 Vascular endothelial cell growth factor variants and uses thereof
11/30/2006	US20060269996 Human voltage gated sodium channel beta1A subunit and methods of use
11/30/2006	US20060269995 Novel assays utilizing nicotinic acetylcholine receptor subunits
11/30/2006	US20060269994 Non-ribosomal peptide synthetases and associated biosynthetic genes
11/30/2006	US20060269991 T cell protein and nucleotides encoding the same
11/30/2006	US20060269989 Process for producing antibodies
11/30/2006	US20060269988 Complete biosynthetic gene set for synthesis of polyketide antibiotics, including the albicidin family, resistance genes, and uses thereof
11/30/2006	US20060269977 Recombinant antibody recognizing dioxin and gene encoding the antibody
11/30/2006	US20060269976 Method for reducing lysozyme enzymatic activity
11/30/2006	US20060269975 Corynebacterium glutamicum genes encoding proteins involved in DNA replication, protein synthesis, and pathogenesis
11/30/2006	US20060269967 Novel diagnosis & treatment tools for cancer using the NRIP antibody and RNA interference
11/30/2006	US20060269961 Dendrimer-based DNA extraction methods and biochips
11/30/2006	US20060269960 Isolated peptides corresponding to amino acid requirements of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof
11/30/2006	US20060269959 Sequences of an Ih ion channel and use thereof
11/30/2006	US20060269958 UV excitable energy transfer reagents
11/30/2006	US20060269957 Nucleotide sequences coding protein factors for use in identifying modulators for diagnosis, treatment and prevention of cell proliferative, metabolic, inflammatory, nervous system and immune disorders
11/30/2006	US20060269940 Normalized nucleic acid libraries and methods of production thereof
11/30/2006	US20060269938 Polynucleotides encoding insect plasma membrane ca2+ ATPase and uses thereof
11/30/2006	US20060269936 Drug screening for agonists and antagonists to toll-like receptors using mutant TLR proteins containing deletions in extracellular leucine rich regions (LRRs); viricides, anticarcinogenic agents, antiallergens, antihistamines, bronchodilator agents; chronic obstructive pulmonary disease, asthma
11/30/2006	US20060269933 Base sequence for control probe and method of designing the same
11/30/2006	US20060269929 Methods and kits for DNA purification on polymeric membranes at low ionic strength
11/30/2006	US20060269922 comprising a flexible real time PCT instrument and a specific composition or reaction mixture for performing multiplex PCR
11/30/2006	US20060269918 Compositions, splice variants and methods relating to colon specific genes and proteins
11/30/2006	US20060269917 Compositions, splice variants and methods relating to colon specific gene and proteins
11/30/2006	US20060269916 Probes
11/30/2006	US20060269566 Polypeptide comprising extracellular domain which induces T-cell proliferation response; gene therapy; vaccines; antiproliferative/antitumor agents; cytotoxic T-lymphocyte (CTLA)
11/30/2006	US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis
11/30/2006	US20060269563 NMB1343 from Neisseria meningitidis; provides a mutant toxin having a substitution at one or more of amino Glu-109, Glu-111 or Glu-120; has reduced or eliminated ADP-ribosyltransferase and/or NAD-glycohydrolase activity
11/30/2006	US20060269562 Polypeptides f' of the hepatitis c virus, t epitopeo, and the diagnostic and therapeutic applications thereof
11/30/2006	US20060269559 Novel human histone deacetylases
11/30/2006	US20060269557 Humanized anti-prostate stem cell antigen monoclonal antibody
11/30/2006	US20060269554 DR5 antibodies and uses thereof
11/30/2006	US20060269550 Anti-ghrelin fab antibodies
11/30/2006	US20060269546 Androgen-regulated PMEPA1 gene and polypeptides
11/30/2006	US20060269545 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
11/30/2006	US20060269544 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, BGS42
11/30/2006	US20060269541 S.agalactiae antigens I + II
11/30/2006	US20060269539 Genetic engineering; Alzheimer's agents; anticancer agents
11/30/2006	US20060269538 Serine proteases with altered sensitivity to activity-modulating substances
11/30/2006	US20060269537 Glycosyl phosphatidyl inositol specific phospholipase D proteins and uses thereof
11/30/2006	US20060269536 Inhibitor proteins of a protease and use thereof
11/30/2006	US20060269532 Compositions and methods for the therapy and diagnosis of prostate cancer
11/30/2006	US20060269530 RNA interference compositions and methods
11/30/2006	US20060269515 Interleukin-2 muteins
11/30/2006	DE102005023829A1 Allele des opcA-Gens aus coryneformen Bakterien Alleles of the gene from coryneform bacteria opcA
11/30/2006	CA2609365A1 Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (tina) and process for the preparation of tina
11/30/2006	CA2607852A1 Transgenic alzheimer's mouse model vectors and uses thereof
11/30/2006	CA2601554A1 Compounds and methods for labeling oligonucleotides
11/29/2006	EP1725686A2 Compositions for use in identification of bacteria
11/29/2006	EP1725680A2 Dutp based compositions for reducing primer-aggregate formation during nucleic acid amplification
11/29/2006	EP1725678A1 Differential drug sensitivity
11/29/2006	EP1725661A1 Polynucleotides for the detection of escherichia coli o157
11/29/2006	EP1725660A2 Multiple promoter expression cassettes for simultaneous delivery of rnai agents
11/29/2006	EP1725659A2 Natural igm antibodies and inhibitors thereof
11/29/2006	EP1725574A1 Thrombomodulin (thbd) haplotypes predict outcome of patients
11/29/2006	EP1725572A2 Macromolecular nucleotide compounds and methods for using the same
11/29/2006	EP1725251A2 Selective incorporation of 5-hyroxytrypophan into proteins in mammalian cells
11/29/2006	EP1725111A2 Methods and compositions for inhibition of metastasis
11/29/2006	EP1478774A4 Nanoparticles having oligonucleotides attached thereto and uses therefor
11/29/2006	EP1412517B1 Methods, kits and compositions of combination oligomers
11/29/2006	EP1390545B1 Device and biological sample processing methods
11/29/2006	EP1385860B1 Immobilization of oligonucleotides onto solid supports
11/29/2006	EP1356115B1 Methods for detection of chloral hydrate in dichloroacetic acid
11/29/2006	EP1088066B1 Antisense oligonucleotide constructs based on beta-arabinofuranose and its analogues
11/29/2006	EP0785716B1 Cytokine designated lerk-6
11/29/2006	CN1871357A Compositions and methods for altering biosynthesis of taxanes and taxane-related compounds
11/29/2006	CN1871352A Compositions and methods for regulating polysaccharides of a plant cell
11/29/2006	CN1871348A Nucleic acid-adsorbing porous membrane for separating and purifying nucleic acid and apparatus for separating and purifying nucleic acid
11/29/2006	CN1871346A Engineering single-gene-controlled staygreen potential into plants
11/29/2006	CN1871252A Method for the production of fusion proteins in transgenic mammal milk
11/29/2006	CN1869220A Application of ShRNA pointed at HBV gene in inhibiting hepatitis B virus duplication
11/29/2006	CN1869216A Expression method of recombination human bone formation protein-2
11/29/2006	CN1869062A Polypeptide for inhibiting gelatin enzyme A activity and its preparation method and application
11/29/2006	CN1869042A Antisensedigonucleotide structure with withor inhibiting factor survivin gene as target and its use
11/29/2006	CN1286976C Interferon-alpha/beta binding protein, its preparation and use
11/29/2006	CN1286530C Self-regulated apoptosis of inflammatory cells by gene therapy
11/28/2006	US7141722 Glyphosate resistant plants using hybrid promoter constructs
11/28/2006	US7141721 Transformed cells; genetic engineering; corn, rice, soybeans

1 ... 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 ... 899